Stay updated on Dapagliflozin and Autonomic Function in T2D Clinical Trial
Sign up to get notified when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.

Latest updates to the Dapagliflozin and Autonomic Function in T2D Clinical Trial page
- CheckyesterdayChange DetectedUpdated the page from v3.0.1 to v3.0.2; the 'Back to Top' link was removed.SummaryDifference0.2%
- Check8 days agoChange DetectedThe web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes in core content or other important factors.SummaryDifference0.2%
- Check15 days agoChange DetectedThe web page has undergone significant updates, including the addition of a facility name and location, as well as new topics related to public health practices and investigative techniques. Notably, specific medications such as dapagliflozin and glimepiride have been retained, while many related medical topics and terms have been removed.SummaryDifference3%
- Check23 days agoChange DetectedThe web page has been updated from version 2.16.11 to version 2.16.12.SummaryDifference0.1%
- Check37 days agoChange DetectedThe web page has been updated from version 2.16.10 to version 2.16.11.SummaryDifference0.1%
- Check44 days agoChange DetectedThe web page has been updated to version 2.16.10 and now includes a section on HHS Vulnerability Disclosure. The previous version 2.16.6 has been removed along with a service alert regarding planned maintenance.SummaryDifference1.0%
Stay in the know with updates to Dapagliflozin and Autonomic Function in T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Dapagliflozin and Autonomic Function in T2D Clinical Trial page.